HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence of hepatic dysfunction is equivalent in burn patients receiving oxandrolone and controls.

Abstract
Oxandrolone has been shown to improve lean muscle mass in patients with burns. Hepatic dysfunction is a known side effect of treatment with oxandrolone. The purpose of this study was to examine the incidence of hepatic dysfunction in our series of burn patients receiving oxandrolone. Fourteen patients who received oxandrolone (5 mg, n = 8; 10 mg, n = 6) were identified from our prospectively collected burn database. The records of 61 control patients also were reviewed. Demographics such as age, comorbidities, and burn size were recorded. The incidence of hepatic dysfunction was determined by the presence of abnormal liver function tests. The study and control groups were similar in age and burn size. Two of the eight (25%) oxandrolone patients receiving 5 mg and four of the six (67%) oxandrolone patients receiving 10 mg had evidence of hepatic dysfunction. Twenty six of the 61 (43%) control patients had evidence of hepatic dysfunction (P = NS). There appears no significant increased incidence of hepatic dysfunction in burn patients who received oxandrolone compared to those who did not.
AuthorsMona C McCullough, Nicholas Namias, Carl Schulman, Ellie Gomez, Ron Manning, Seth Goldberg, Louis Pizano, Gillon C Ward
JournalJournal of burn care & research : official publication of the American Burn Association (J Burn Care Res) 2007 May-Jun Vol. 28 Issue 3 Pg. 412-20 ISSN: 1559-047X [Print] England
PMID17438485 (Publication Type: Journal Article)
Chemical References
  • Anabolic Agents
  • Androgens
  • Oxandrolone
  • Aspartate Aminotransferases
  • Alanine Transaminase
Topics
  • Adult
  • Alanine Transaminase (drug effects)
  • Anabolic Agents (adverse effects, therapeutic use)
  • Androgens (adverse effects, therapeutic use)
  • Aspartate Aminotransferases (drug effects)
  • Body Composition (drug effects)
  • Burns (drug therapy)
  • Case-Control Studies
  • Chemical and Drug Induced Liver Injury
  • Female
  • Humans
  • Incidence
  • Liver (drug effects)
  • Male
  • Middle Aged
  • Oxandrolone (adverse effects, therapeutic use)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: